Clinical Trials Browser

Withdrawn × Observational × Genitourinary × Clear all

NCT04243473 2026-03-03

Biopsy Collection for Men Undergoing Brachytherapy for Prostate Cancer

Prostatic Neoplasms

NCT02869282 2025-09-17

CHEMOPROST

Prostatic Neoplasms

NCT04688333 2025-06-26

iConquerFear Program for the Treatment of Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma

Carcinoma, Renal Cell

NCT04889495 2025-03-19

A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer

BreastGastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Kidney Neoplasms, Colorectal Neoplasms

NCT06457854 2025-03-12

PROCeed-BR

Prostatic Neoplasms

NCT02608359 2025-02-03

A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer

Prostatic Neoplasms

NCT02905201 2025-02-03

TOGETHER

Prostatic Neoplasms

NCT04495959 2025-01-08

Dynamic Whole Body PET/ MRI

Prostatic Neoplasms

NCT01350180 2024-12-10

Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis

Prostatic Neoplasms

NCT02588404 2024-12-10

The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient

Prostatic Neoplasms

NCT04985357 2024-11-25

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

BreastEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Anus Neoplasms, Appendiceal Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Laryngeal Neoplasms, Lip Neoplasms, Lung Neoplasms, Mesothelioma, Mouth Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Paranasal Sinus Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Thymoma, Vulvar Neoplasms, Pleural Effusion, Malignant, Carcinoma, Neuroendocrine, Cholangiocarcinoma, Carcinoma, Ductal, Small Cell Lung Carcinoma

NCT03990194 2024-10-31

LEPTO

Prostatic Neoplasms

NCT04583553 2024-10-15

VS-UrineID

Urinary Bladder Neoplasms, Urinary Tract Infections

NCT05860543 2024-09-25

Clinical Performance Evaluation of the C2i Test

Muscle Invasive Bladder Cancer

NCT06536244 2024-08-02

Impact of Perioperative Anesthetic Management on Renal Cancer Progression.

Kidney Neoplasms

NCT05335707 2024-02-28

Longitudinal Geriatric Assessment to Optimize Outcomes of Older Patients With Muscle-Invasive Bladder Cancer After Radical Cystectomy

Urinary Bladder Neoplasms

NCT03970863 2024-02-09

Focal Therapy for Localized Prostate Cancer

Prostatic Neoplasms

NCT00323180 2024-01-11

Investigation of Protein Biomarkers of Prostate Cancer

Prostatic Neoplasms

NCT00323388 2024-01-11

Identification of Risk Allels for Prostate Cancer

Prostatic Neoplasms

NCT03494803 2023-12-22

Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC

Prostatic Neoplasms

NCT06159998 2023-12-07

New Markers for Treatment Response to Radiotherapy in Prostate Cancer

Prostatic Neoplasms

NCT04555603 2023-11-21

Axitinib Therapy Management Study

Carcinoma, Renal Cell

NCT01792882 2023-02-28

GBCPRT0008

BreastGastrointestinalGenitourinaryOther hematologic neoplasmThoracic

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms

NCT00581503 2022-10-20

Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate Cancer

GenitourinaryThoracic

Lung Neoplasms, Prostatic Neoplasms

NCT04630483 2022-05-04

Platelet-lymphocyte and Neutrophil-lymphocyte Ratio in Patients Undergoing Cancer Surgery

Neoplasms, Urologic Neoplasms

NCT05260788 2022-04-14

Mapping 3D Bladder

Urinary Bladder Neoplasms

NCT04339920 2022-01-04

Spermine Measuring Device Evaluation Protocol

Prostatic Neoplasms

NCT03495479 2021-10-18

CAMPAS

Prostatic Neoplasms

NCT00161252 2021-09-27

Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among Elderly

Prostatic Neoplasms

NCT04680416 2021-08-25

Tissue Collection to ID TCRs From Renal Clear Cell Carcinoma Patients Responding to Immune Checkpoint Inhibitors

Carcinoma, Renal Cell

NCT01401777 2021-04-27

Electromagnetic Tracking of Devices During Interventional Procedures - A Cryoablation Study

Carcinoma, Renal Cell

NCT04609800 2020-12-21

CAROLINE

Carcinoma, Renal Cell

NCT03563352 2020-12-14

Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer

BreastGastrointestinalGenitourinary

Breast Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT02822963 2020-10-06

Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate

Prostatic Hyperplasia, Prostatic Neoplasms

NCT01739738 2020-03-25

The Impact of Ureteral Stents on Peristalsis

Hydronephrosis, Kidney Calculi, Neoplasms

NCT01766869 2020-03-18

GCC 1261

Prostatic Neoplasms

NCT00980993 2019-11-04

Quantification of Respiratory-induced Prostate Motion

Prostatic Neoplasms, Respiratory Aspiration

NCT00538772 2019-07-11

An Exploratory Correlative Study of Biomarkers in Patients With Metastatic Renal Cell Carcinoma Who Have Progressed After Sunitinib Therapy

Carcinoma, Renal Cell

NCT02428335 2019-07-05

Study of Muscle Energy Metabolism in RCC Patients Treated With Sunitinib

Carcinoma, Renal Cell, Fatigue

NCT01060319 2019-04-18

A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies

DermatologicGenitourinary

Urinary Bladder Neoplasms, Neoplasms, Skin Neoplasms

NCT02867345 2019-03-06

PD-1 Knockout Engineered T Cells for Castration Resistant Prostate Cancer

Hormone Refractory Prostate Cancer

NCT01275651 2019-01-24

Biomarkers in Bone Marrow and Blood Samples From Patients With Prostate Cancer Treated With Ketoconazole

Prostatic Neoplasms

NCT03296124 2018-11-16

PRX32

Prostatic Neoplasms

NCT03325127 2018-10-31

Outcomes of mCRPC Patients Treated With Ra-223 Concomitant With Abiraterone or Enzalutamide- A Chart Review Study

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT00562341 2018-08-23

Effect of Lap-Band Induced Weight Loss on Serum PSA Levels

GenitourinaryHead & NeckOther

Salivary Gland Adenoma, Pleomorphic, Obesity, Prostatic Neoplasms

NCT00922818 2018-08-20

RPP

Neoplasms, Prostatic Neoplasms, Recurrence

NCT01642095 2018-08-07

Studying Biomarkers in Samples From Younger Patients With Kidney Cancer

Carcinoma, Renal Cell, Nephroma, Mesoblastic

NCT02492360 2018-02-28

Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy

Peripheral Nervous System Diseases, Testicular Neoplasms

NCT02514408 2018-01-02

Circulating Tumor Cells in Operative Blood in Patients With Bladder Cancer

Stage II Bladder Urothelial Carcinoma

NCT01260909 2017-12-02

Real-Time MV/kV Image Guided Radiation Therapy

Prostatic Neoplasms